New England Biz Law Update

A recently filed trademark suit could potentially curtail online advertisers from using other companies’ trademarks to trigger web advertisements for their company. This occurs when an advertiser pays a search engine, such as Google, to have links to its company’s ...

Award is part of a $134 million verdict to three women

With outside counsel fees starting to break the $1,000 per-hour barrier, in-house attorneys need to reevaluate how to get the best value from their outside counsel. The billing issue hit the radar in the middle of last year, when the first Manhattan firms announced hourly rate increases, and the Wall Street Journal called the $1,000 number the possible “vomit point” for clients.

Three Nevada women recently won the biggest verdict yet in the ongoing hormone replacement therapy litigation against Wyeth – convincing a jury the company knew its drugs caused breast cancer but failed to test them or warn patients about the ...

A recent U.S. Supreme Court decision that the statute of limitations on a Title VII disparate pay claim is triggered when the original decision on salary is made – and no new violation occurs each time a paycheck is issued ...

With a new chair in office and a new general counsel recently taking the helm, the Equal Employment Opportunity Commission plans to pursue class actions, and to continue its restructuring plan and functioning as a “national law firm,” with district ...

With new Securities and Exchange Commission enforcement proceedings and shareholder suits over stock option backdating cropping up more and more, attorneys should be urging public companies to complete internal investigations of their options practices. The SEC is investigating more than ...

With the Hewlett-Packard scandal putting the possible risks of private investigation on the radar screen, management lawyers are advising clients about what they should and should not do when they want to investigate an employee. H-P is under scrutiny for ...

The new prescription drug labeling rule from the Food and Drug Administration asserts that if a label meets the agency’s requirements, state law failure-to-warn suits over the drug’s risks are preempted. And experts predict courts are likely to defer to ...

Three years after Sarbanes-Oxley went into effect to regulate publicly traded companies, its complex requirements are making their way into the non-profit sector – and health care lawyers are advising hospitals to pay attention. For non-profit hospitals and their attorneys, ...